UBS Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-1,277,342
| Closed | -$108M | – | 7589 |
|
|
2019
Q4 | $108M | Buy |
1,277,342
+754,143
| +144% | +$64.1M | 0.04% | 335 |
|
|
2019
Q3 | $26.2M | Buy |
523,199
+301,105
| +136% | +$15.1M | 0.01% | 833 |
|
|
2019
Q2 | $8.1M | Sell |
222,094
-285,428
| -56% | -$10.4M | ﹤0.01% | 1508 |
|
|
2019
Q1 | $14.2M | Buy |
507,522
+93,855
| +23% | +$2.62M | 0.01% | 1131 |
|
|
2018
Q4 | $7.92M | Buy |
413,667
+348,310
| +533% | +$6.67M | ﹤0.01% | 1394 |
|
|
2018
Q3 | $1.95M | Buy |
65,357
+17,490
| +37% | +$523K | ﹤0.01% | 2627 |
|
|
2018
Q2 | $1.76M | Buy |
47,867
+2,225
| +5% | +$81.7K | ﹤0.01% | 2637 |
|
|
2018
Q1 | $1.5M | Buy |
45,642
+4,059
| +10% | +$134K | ﹤0.01% | 2731 |
|
|
2017
Q4 | $1.14M | Sell |
41,583
-13,677
| -25% | -$374K | ﹤0.01% | 2935 |
|
|
2017
Q3 | $2.05M | Buy |
55,260
+53
| +0.1% | +$1.96K | ﹤0.01% | 2480 |
|
|
2017
Q2 | $2.1M | Buy |
55,207
+6,631
| +14% | +$252K | ﹤0.01% | 2367 |
|
|
2017
Q1 | $2.38M | Buy |
48,576
+35,012
| +258% | +$1.71M | ﹤0.01% | 2218 |
|
|
2016
Q4 | $461K | Sell |
13,564
-126,168
| -90% | -$4.29M | ﹤0.01% | 3375 |
|
|
2016
Q3 | $5.27M | Buy |
139,732
+124,214
| +800% | +$4.69M | ﹤0.01% | 1506 |
|
|
2016
Q2 | $522K | Sell |
15,518
-616
| -4% | -$20.7K | ﹤0.01% | 3117 |
|
|
2016
Q1 | $512K | Buy |
16,134
+8,494
| +111% | +$270K | ﹤0.01% | 3107 |
|
|
2015
Q4 | $285K | Buy |
7,640
+103
| +1% | +$3.84K | ﹤0.01% | 3533 |
|
|
2015
Q3 | $286K | Buy |
7,537
+2,465
| +49% | +$93.5K | ﹤0.01% | 3477 |
|
|
2015
Q2 | $145K | Sell |
5,072
-366
| -7% | -$10.5K | ﹤0.01% | 4070 |
|
|
2015
Q1 | $152K | Buy |
5,438
+471
| +9% | +$13.2K | ﹤0.01% | 3955 |
|
|
2014
Q4 | $138K | Buy |
+4,967
| New | +$138K | ﹤0.01% | 4004 |
|